NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Daiichi Sankyo Company  »  News  »   Daiichi Sankyo Company

  News for Daiichi Sankyo Company

  • News
  • Business

Abe, Singh to meet today; investment deals likely

The annual summit between India and Japan on Saturday will seek to forge greater bilateral trade and investment ties, with Japanese Prime Minister Shinzo Abe coming with a high-powered business......

The mistakes Daiichi Sankyo made in the Ranbaxy deal

'Love for the deal' was evident when Daiichi termed the investigations by the US Foods and Drugs Administration (FDA) as just a "risk call" and did not spend enough time on evaluating the risk,......

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Drug major Sun Pharmaceutical on Wednesday said its promoter and managing director Dilip Shanghvi did not buy shares of the company sold by the Japanese drugmaker Daiichi Sankyo. ". . .Dilip......

Daiichi Sankyo to offload stake in Sun Pharma

Japanese drug maker Daiichi Sankyo on Monday said its board has approved selling a part or entire 9 per cent holding worth over Rs 22,000 crore (Rs 220 billion) in Indian drug major Sun......

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees......

Daiichi and Docomo go, but India remains a hot market for the Japanese

The decision of two marquee Japanese names -- Daiichi Sankyo and NTT Docomo -- to exit their Indian investments might give an impression that investors from that country are treading cautiously on......
  Web results for Daiichi Sankyo Company
Daiichi Sankyo announces phase 3 trial results for prasugrel antiplatelet agent for ischemic cerebrovascular disease patients

Daiichi Sankyo Company, Limited, announced the results of phase 3 clinical trials in Japan of the antiplatelet agent prasugrel hydrochloride... ...
I-banking fee pool down 40%

The fees earned by investment banks on equity-related capital raising transactions have shrunk this year, despite a boom in the initial public... ...
NY/NJ CEO Conference to Feature Prominent Biotech and Pharmaceutical Leaders on November 2nd 3rd at Apella in New York City

PRWeb 2016-10-21 Join some of the biggest names in biotech and pharmaceuticals including Emmanuel Caeymaex (UCB),Ron Cohen (Acorda), Mikael... ...
Biosimilars Accounted for Approx 9% of the Prescription Drugs Market as a..

/PRNewswire/ -- Research and Markets has announced the addition of the "The Overview of Biosimilar Market in Japan ver2016" report to their... ...
Rigel Announces Results from the Second FIT Phase 3 Study and the Long-Term Open-Label Extension Study for..

SOUTH SAN FRANCISCO, Calif. , Oct. 20, 2016 /PRNewswire/ --Rigel Pharmaceuticals,Inc.(Nasdaq:RIGL) today announced results for the second of two... ...

Related Tags

  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages

daiichi sankyo company
Daiichi Sankyo


Top Coverage News

Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z